Chief Executive Officer of Pharmaceuticals & Medical Devices Bureau of India (PMBI) Mr Ravi Dadhich launched Sitagliptin a new variant of medicines for diabetes today at affordable prices for all under the Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana.

PMBI will sell new variants of medicines Sitagliptin and its combination in its all Jan Aushadhi Kendras. The details are as follows:

Name of Product & MRP for Pack of 10

(1) Sitagliptin Phosphate Tablet IP 50mg   Rs. 60/-

(2) Sitagliptin Phosphate Tablet IP 100mg  Rs. 100/-

(3) Sitagliptin + Metformin Hydrochloride Tablets 50mg/500mg  Rs. 65/-

(4) Sitagliptin + Metformin Hydrochloride Tablets 50mg/1000mg  Rs. 70/-

Sitagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. All these variants are available at 60% to 70% lesser prices than branded variants as they are available in the price band of Rs. 162 to Rs. 258  at other medical stores.

Under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana, more than 8700 Pradhan Mantri Bhartiya Janaushadhi Kendras have been opened across the country. These Kendras are selling quality generic medicines, surgical equipment, nutraceuticals and other products. At present, these Kendras make available more than 1600 medicines and 250 surgical devices including Suvidha Sanitary pads which are sold at Re 1 per pad.